Blood Group Typing Market Size Analysis 2019: Global Industry Analysis, Recent Trends and Technique, Product type, Busin

1. Blood Group Typing Market Size Analysis 2019: Global Industry Analysis, Recent Trends and Technique, Product type, Business Opportunities and I Forecast 2023 Global blood group typing market size is forecast to grow USD 1.36 billion during 2019-2023 at a CAGR of 10%, with the consumables segment having the largest market share. This blood group typing market analysis indicates growth will be driven by the increasing R&D activities focused on analyzing the molecular level of blood group typing and will also be impacted by the increasing government support pertaining to blood safety Biotechnology and healthcare companies are focusing on the development of new technologies and products to analyze the molecular level of blood group typing. Companies are also developing products which enable efficient blood testing workload management thereby helping them to increase their market share. For instance, the PreciseType HEA Test developed by Immucor has received US FDA approval and is used for sickle cell trait (SCT) screening in blood donors. Thus, the increasing R&D activities and product innovations related to the analysis of the molecular level of blood group typing will drive the growth of the market. Furthermore, this industry research report also presents a competitive analysis of the market by product (consumables, instruments, and software) and geography (Asia, Europe, North America, and ROW). Competitive vendor landscape The global blood group typing market is highly competitive with major vendors such as Agena Bioscience, Bio-Rad Laboratories, Danaher, Merck KGaA, and Ortho Clinical Diagnostics, competing on the basis of price, quality, and product/service offerings. Top five blood group typing market vendors Agena Bioscience

2. Agena Bioscience operates through the segment: unified business segment. The company’s key offerings include Hemo ID DQS Panel and Hemo ID software. Bio-Rad Laboratories Bio-Rad Laboratories operates through three segments: life science, clinical diagnostics, and other operations. The company’s key offerings include: ABO/Rh Reagents and TANGO infinity System. Danaher Danaher operates through four segments: life sciences, diagnostics, dental, environmental & applied solutions. The company’s key offerings include PK7300 Automated Microplate System. Merck KGaA Merck KGaA operates through three segments: healthcare, life science, and performance materials. The company’s key offerings include BIOSCOT Blood Typing Reagents and Blood typing intermediates FFMU. Ortho Clinical Diagnostics Ortho Clinical Diagnostics operates through the segment: unified business segment. The company’s key offerings include: ORTHO VISION Analyzer and ID-Micro Typing System. Looking for more information on this market? Request a free sample report Browse Related Reports: Global Influenza Diagnostics Market 2019-2023 - The market research study identifies Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., and Thermo Fisher Scientific Inc., as the leading players in the global influenza diagnostics market. Global Fecal Occult Testing Market 2019-2023 - The market research study identifies Abbott Laboratories, bioMérieux SA, Danaher Corp., Eiken Chemical Co. Ltd., and Quidel Corp., as the leading players in the global fecal occult testing market. • •